Protect Infant Formula from Contamination Act
Sponsored By: Senator Peters, Gary C. [D-MI]
Passed Senate
Summary
Faster manufacturer reporting and quicker FDA response to contaminated infant formula. This bill would require quicker notifications and set a time‑bound federal reporting and coordination framework to strengthen formula safety and supply.
Show full summary
- Families and infants get faster detection and clearer supply monitoring, aiming to reduce exposure to contaminated formula and limit shortages.
- Manufacturers must notify FDA within 1 business day if finished formula tests positive for specified microorganisms or if processed product may be adulterated. They must provide test results or isolates, consult with FDA, and may be required to stop distribution and dispose of affected product.
- FDA must begin discussions with manufacturers within 1 business day of a notice and confirm within 90 days that appropriate investigations and corrective actions are underway. The agency must also deliver progress updates, regular supply‑chain reports, and consult with other federal agencies and stakeholders.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Faster alerts on tainted baby formula
If enacted, when a required safety test on finished infant formula finds contamination, the maker would have to tell the FDA within 1 business day, even if the product never left the plant. The maker would need to work with the FDA to isolate the affected product and, if required, stop distribution and dispose of it. The maker would also have to share test results and isolates or whole‑genome data. The FDA would start talks within 1 business day and, within 90 days, would confirm the maker is doing proper investigation and fixes. Companies would have to provide documents electronically for FDA review.
Stronger tracking and coordination on baby formula
If enacted, the FDA would send Congress a progress report within 180 days on its plan to strengthen the formula market. The FDA would then send supply reports with in‑stock rates within 270 days and at least every quarter for five years. The FDA would meet with the public and formula makers and report at 1, 3, and 5 years on evidence‑based steps to improve safety and supply, like frequent testing and isolating risky batches. The FDA would also work with the Department of Agriculture and other agencies to meet urgent needs and build long‑term resiliency.
Sponsors & CoSponsors
Sponsor
Peters, Gary C. [D-MI]
MI • D
Cosponsors
Sen. Hoeven, John [R-ND]
ND • R
Sponsored 1/28/2025
Sen. Collins, Susan M. [R-ME]
ME • R
Sponsored 3/3/2025
Sen. Smith, Tina [D-MN]
MN • D
Sponsored 3/3/2025
Sen. Shaheen, Jeanne [D-NH]
NH • D
Sponsored 3/12/2025
Sen. Hassan, Margaret Wood [D-NH]
NH • D
Sponsored 9/3/2025
Sen. Kaine, Tim [D-VA]
VA • D
Sponsored 1/12/2026
Sen. Baldwin, Tammy [D-WI]
WI • D
Sponsored 1/13/2026
Sen. Murray, Patty [D-WA]
WA • D
Sponsored 1/29/2026
Sen. Fischer, Deb [R-NE]
NE • R
Sponsored 2/10/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov